Fig. 2

(a) The proportion of naturally infected participants- who were seropositive for anti-S antibodies. (b) The proportion of naturally infected participants who were seropositive for anti-N antibodies produced. (c) The proportion of vaccinated participants who were seropositive for anti-S antibodies. (d) The proportion of vaccinated participants who were seropositive for anti-N antibodies